Chelation of chromium(VI) by combining deferasirox and deferiprone in rats
- First Online:
- 206 Downloads
The present research is aimed to characterize the potential efficiency of two chelators after chromium(VI) administration for 60 days following two doses of 15 and 30 mg/kg chromium(VI) per body weight daily to male rats. However, the hypothesis that the two chelators might be more efficient as combined therapy than as single therapy in removing chromium(VI) from rat organs was considered. In this way, two known chelators deferasirox and deferiprone were chosen and given orally as a single or combined therapy for a period of 1 week. Chromium(VI) and iron concentrations in tissues were determined by flame atomic absorption spectroscopy. The combined chelation therapy results show that deferasirox and deferiprone are able to remove chromium(VI) ions from various tissues while iron concentration returned to normal levels and symptoms also decreased.
KeywordsDeferasirox Deferiprone Chromium toxicity Chelation therapy Rats
- Agency for Toxic Substances and Diseases Registry (ATSDR) (1998) Toxicological profile for chromium. Public Health Service. US Department of Health and Human Services, AtlantaGoogle Scholar
- Hershko C, Konijn AM, Nick HP, Breuer W, Cabantchik ZI, Link G (2001) ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture. Blood 97:1115–1122CrossRefPubMedGoogle Scholar
- Hider RC, Kontoghiorghes G, Silver J (1984) Pharmaceutical compositions. GB patent 2118176 AGoogle Scholar